RISE: A Remote Study of Insomnia Treatment in Crohn's Disease

Description

The purpose of this study is to assess whether the investigators can treat insomnia in people with Crohn's disease, and if insomnia treatment can make other things better, like pain or inflammation.

Conditions

Insomnia, Crohn Disease

Study Overview

Study Details

Study overview

The purpose of this study is to assess whether the investigators can treat insomnia in people with Crohn's disease, and if insomnia treatment can make other things better, like pain or inflammation.

RISE: A Remote Study of Insomnia Treatment in Crohn's Disease

RISE: A Remote Study of Insomnia Treatment in Crohn's Disease

Condition
Insomnia
Intervention / Treatment

-

Contacts and Locations

Lebanon

Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States, 03756

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Mild to moderate CD based on PRO-3 \& 50% with objective evidence of active disease
  • * Insomnia Severity Index score ≥ 8 and SOL or WASO ≥ 30 minutes
  • * Stability of sleep \& CD meds for ≥ 3 months
  • * Access to internet or cell phone service sufficient for telehealth
  • * PHQ-9 depression score ≥ 15
  • * GAD-7 anxiety score ≥ 15
  • * Unstable major psychiatric condition (e.g., bipolar disorder, psychotic disorder)
  • * Current alcohol or substance abuse
  • * Current opioid use for pain control
  • * Current systemic corticosteroid use
  • * Current pregnancy or nursing
  • * Ileostomy or colostomy
  • * Diagnosis of seizure disorder
  • * Diagnosis of sleep apnea or positive WatchPAT screen
  • * Diagnosis of restless leg syndrome or positive Cambridge-Hopkins RSLq screen
  • * Night shift, rotating shift work, or frequent travel outside of time zone

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Dartmouth-Hitchcock Medical Center,

Study Record Dates

2026-10-01